RecruitingNCT02760238

Myeloproliferative Neoplasms (MPNs) Patient Registry

Clinical and Molecular Epidemiology of Myeloproliferative Neoplasms (MPNs)


Sponsor

University Health Network, Toronto

Enrollment

5,000 participants

Start Date

Apr 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.


Eligibility

Plain Language Summary

Simplified for easier understanding

This is a patient registry — a database — for people with myeloproliferative neoplasms (MPNs), a group of rare bone marrow disorders where too many blood cells are produced, used to track disease patterns and outcomes over time. **You may be eligible if...** - You have been diagnosed with any of the following blood marrow disorders: essential thrombocythemia (too many platelets), polycythemia vera (too many red blood cells), primary myelofibrosis (bone marrow scarring), chronic myelomonocytic leukemia, chronic neutrophilic leukemia, chronic eosinophilic leukemia, juvenile myelomonocytic leukemia, mastocytosis, atypical CML, or related overlap syndromes **You may NOT be eligible if...** - There are no specific exclusion criteria — anyone with an MPN diagnosis may be eligible Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservational

Locations(1)

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02760238


Related Trials